Old Web
English
Sign In
Acemap
>
Paper
>
Maintenance sorafenib in FLT3-ITD AML following allogeneic HCT favorably impacts relapse and overall survival
Maintenance sorafenib in FLT3-ITD AML following allogeneic HCT favorably impacts relapse and overall survival
2019
Grant Chappell
Marcus Geer
Erin Gatza
Thomas M. Braun
Tracey Churay
Joseph Brisson
Dale Bixby
Bernard L. Marini
Anthony J. Perissinotti
David Frame
Brian Parkin
Pavan Reddy
John Magenau
Sung Won Choi
Keywords:
Immunology
Diabetes mellitus
Oncology
Sorafenib
Medicine
Internal medicine
allogeneic hct
flt3 itd
overall survival
Correction
Source
Cite
Save
Machine Reading By IdeaReader
14
References
13
Citations
NaN
KQI
[]